↓ Skip to main content

An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas

Overview of attention for article published in BMC Cancer, February 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
1 news outlet
twitter
1 X user
patent
2 patents
facebook
1 Facebook page
googleplus
1 Google+ user

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
31 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas
Published in
BMC Cancer, February 2014
DOI 10.1186/1471-2407-14-137
Pubmed ID
Authors

Clara Guerzoni, Stefano Amatori, Luca Giorgi, Maria Cristina Manara, Lorena Landuzzi, Pier-Luigi Lollini, Aurora Tassoni, Mauro Balducci, Marco Manfrini, Loredana Pratelli, Massimo Serra, Piero Picci, Mauro Magnani, Vieri Fusi, Mirco Fanelli, Katia Scotlandi

Abstract

Identification of new drugs against paediatric sarcomas represents an urgent clinical need that mainly relies on public investments due to the rarity of these diseases. In this paper we evaluated the in vitro and in vivo efficacy of a new maltol derived molecule (maltonis), belonging to the family of molecules named hydroxypyrones.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Switzerland 1 3%
Unknown 30 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 23%
Student > Ph. D. Student 6 19%
Student > Postgraduate 4 13%
Student > Doctoral Student 3 10%
Student > Master 3 10%
Other 6 19%
Unknown 2 6%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 10 32%
Medicine and Dentistry 7 23%
Agricultural and Biological Sciences 4 13%
Psychology 2 6%
Chemistry 1 3%
Other 0 0%
Unknown 7 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 January 2018.
All research outputs
#1,952,037
of 25,385,864 outputs
Outputs from BMC Cancer
#297
of 8,950 outputs
Outputs of similar age
#19,089
of 230,896 outputs
Outputs of similar age from BMC Cancer
#9
of 142 outputs
Altmetric has tracked 25,385,864 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,950 research outputs from this source. They receive a mean Attention Score of 4.8. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 230,896 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 142 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.